0.804
Schlusskurs vom Vortag:
$0.8395
Offen:
$0.86
24-Stunden-Volumen:
313.30K
Relative Volume:
0.99
Marktkapitalisierung:
$84.84M
Einnahmen:
$238.26M
Nettoeinkommen (Verlust:
$-236.56M
KGV:
-0.4938
EPS:
-1.6281
Netto-Cashflow:
$27.06M
1W Leistung:
-5.02%
1M Leistung:
-0.48%
6M Leistung:
-65.04%
1J Leistung:
-77.97%
Definitive Healthcare Corp Stock (DH) Company Profile
Firmenname
Definitive Healthcare Corp
Sektor
Branche
Telefon
508-720-4224
Adresse
492 OLD CONNECTICUT PATH, SUITE 401, FRAMINGHAM
Compare DH vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
DH
Definitive Healthcare Corp
|
0.804 | 88.59M | 238.26M | -236.56M | 27.06M | -1.6281 |
|
VEEV
Veeva Systems Inc
|
162.17 | 25.92B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
64.08 | 12.41B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
52.32 | 8.59B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
86.97 | 7.39B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
HNGE
Hinge Health Inc
|
68.35 | 5.06B | 646.34M | -512.40M | 202.76M | -6.6871 |
Definitive Healthcare Corp Stock (DH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-01-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-09-17 | Eingeleitet | BTIG Research | Buy |
| 2024-07-31 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-05-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-17 | Herabstufung | Needham | Buy → Hold |
| 2024-01-05 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-07-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2023-04-19 | Eingeleitet | William Blair | Outperform |
| 2022-12-09 | Eingeleitet | BofA Securities | Neutral |
| 2022-07-06 | Eingeleitet | Needham | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2022-02-24 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-12-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-10-11 | Eingeleitet | Barclays | Equal Weight |
| 2021-10-11 | Eingeleitet | Canaccord Genuity | Hold |
| 2021-10-11 | Eingeleitet | Credit Suisse | Neutral |
| 2021-10-11 | Eingeleitet | Deutsche Bank | Hold |
| 2021-10-11 | Eingeleitet | Goldman | Neutral |
| 2021-10-11 | Eingeleitet | JP Morgan | Neutral |
| 2021-10-11 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-10-11 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-10-11 | Eingeleitet | Stifel | Buy |
Alle ansehen
Definitive Healthcare Corp Aktie (DH) Neueste Nachrichten
Definitive Healthcare Corp. (DH) Q1 2026 Earnings: EPS Beats Estimates by 79.1% Amid Stock DeclineProduct Revenue Analysis - newsline.com
DH Q1 2026 Earnings: Earnings Beat Fails to Lift Stock Amid Revenue UncertaintyPost-Earnings Reaction - newsline.com
Definitive Healthcare Corp. (DH) Q1 2026 Earnings: EPS Surges 79% Past Estimates, Stock Slips on No Revenue DisclosureGuidance Accuracy Score - newsline.com
DH News | DEFINITIVE HEALTHCARE CORP (NASDAQ:DH) - ChartMill
Director Hamood receives 189K RSUs at Definitive Healthcare (DH) - Stock Titan
Definitive Healthcare (DH) grants 189,190 RSUs to director Scott G. Stephenson - Stock Titan
Definitive Healthcare (DH) grants 189,190 RSUs to director Kathleen Winters - Stock Titan
Definitive Healthcare (DH) director awarded 189,190 RSUs, holdings now 315,984 shares - Stock Titan
Definitive Healthcare (DH) investors approve equity plan share increase and pay - Stock Titan
Definitive Healthcare Corp. (DH) Q1 2026 Earnings: EPS Surges Past Estimates by 79.1%, Stock DeclinesROIC Trend Report - newsline.com
Definitive Healthcare (DH) CFO has shares withheld to cover RSU tax bill - Stock Titan
Definitive Healthcare (DH) CEO sees 66,050 shares withheld for taxes - Stock Titan
Innoviz Technologies Among 3 Compelling Penny Stocks To Consider - simplywall.st
Definitive Healthcare Q1 2026 Earnings: Strong EPS Beat Driven by Operational EfficiencyCost Structure Review - The Legal Advocate
Definitive Healthcare Stock Jumps, With Traders Watching the $1 Level - Bez Kabli
Definitive Healthcare (DH) Holds Steady Near Support as Biotech Data Firm Attempts RecoveryVolume Profile - The Legal Advocate
Definitive Healthcare (DH) Climbs 1.74% as Shares Test Key Resistance ZoneBullish Pattern Stocks - The Legal Advocate
Definitive Healthcare Corp. (DH) Rallies 3.33%: Approaching Resistance at $0.93Advance Decline Line - newsline.com
Definitive Healthcare (DH) Surges 5.93% as Stock Bounces from Key SupportTick Index - The Legal Advocate
DH Q1 2026 Earnings: EPS Surges 79.1% Above Estimates, Stock Rises 3.9%Revenue Surprise History - newsline.com
Definitive Healthcare Corp. (DH) Q1 2026 Earnings: EPS Surge Beats Expectations, Stock ClimbsROE Trend Analysis - Newser
Definitive Healthcare Corp. (DH) Q1 2026 Earnings: EPS Surges Past Estimates with 79.1% BeatEarnings Growth Forecast - Newser
DH Q1 2026 Earnings: Strong EPS Beat Drives Stock HigherPreliminary Results - newser.com
Definitive Healthcare (DH) Q1 2026 Earnings: EPS Beats Estimates by Wide Margin, Stock RisesTangible Book Value - Newser
Definitive Healthcare (DH) Rallies 4%: Can the Stock Break Above $0.89 Resistance?Hot Momentum Watchlist - Newser
Definitive Healthcare advances data platform and integrations to deliver smarter healthcare insights - Sahm
Definitive Healthcare upgrades data platform wi... | Pluang – Crypto, Stocks, Gold & Funds - Pluang
Sales teams get detailed healthcare data inside Salesforce and HubSpot - Stock Titan
Definitive Healthcare Corp. (DH) Faces Scrutiny After Baird’s Price Target Cut and Q1 LossRevenue Beat Analysis - Newser
Can Definitive Healthcare Corp. (DH) Maintain Stability After Revised Price Target From Baird? - Insider Monkey
Advent International holds 62,493,676 DH shares (NYSE: DH) - Stock Titan
Definitive Healthcare: When The Anchor Shareholder Walks, Pay Attention (NASDAQ:DH) - Seeking Alpha
Analysts Have Made A Financial Statement On Definitive Healthcare Corp.'s (NASDAQ:DH) First-Quarter Report - Yahoo Finance
Definitive Healthcare forecasts $220M-$226M FY2026 revenue while guiding Q2 EBITDA margin at 24%-26% - MSN
Definitive Healthcare (DH) Posts US$9.3 Million Q4 Loss Testing Profit Turnaround Hopes - Sahm
Definitive Healthcare Balances Revenue Pressure With Margin Gains - TipRanks
Definitive Healthcare Q1 2026 slides: margins expand despite revenue drop By Investing.com - Investing.com Nigeria
Definitive Healthcare Corp. (NASDAQ:DH) Q1 2026 Earnings Call Transcript - Insider Monkey
Definitive Healthcare Corp. (DH) Stock Analysis: Exploring A Potential 161% Upside - DirectorsTalk Interviews
Definitive Healthcare Corp. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:DH) 2026-05-08 - Seeking Alpha
Definitive Healthcare Q1 2026 slides: margins expand despite revenue drop - Investing.com
Earnings call transcript: Definitive Healthcare Q1 2026 earnings beat boosts stock - Investing.com
Definitive Healthcare Q1 Earnings Call Highlights - The Globe and Mail
Definitive Healthcare Corp. Q1 2026 Earnings Call Summary - Yahoo Finance
Definitive Healthcare (NASDAQ:DH) Q1 2026 Revenue Beat Drives After-Hours Rally - ChartMill
Definitive Healthcare Corp. (DH) Tops Q1 Earnings Estimates - Yahoo Finance
DH Q1 2026 Earnings Transcript - AOL.com
Definitive Healthcare posts $192M Q1 loss on $197M impairment - Stock Titan
Finanzdaten der Definitive Healthcare Corp-Aktie (DH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):